Agenus Inc. (AGEN) has disclosed a new risk, in the Regulation category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Agenus Inc.’s operational results and financial health remain vulnerable to a variety of risks and uncertainties, as outlined in their Annual Report on Form 10-K for the fiscal year ending December 31, 2024. Despite the passage of time, there have been no significant changes to the risk factors previously identified in Part I, Item 1A of the 2024 Form 10-K. This ongoing exposure to potential risks could impact the company’s performance and investor confidence. Stakeholders should remain vigilant about these persistent uncertainties as they assess the company’s future prospects.
Overall, Wall Street has a Moderate Buy consensus rating on AGEN stock based on 2 Buys and 3 Holds.
To learn more about Agenus Inc.’s risk factors, click here.